- Title
- Shifting The PARADIGM: PrimeC, An Oral Candidate For Amyotrophic Lateral Sclerosis, Demonstrates Safety, Efficacy, And Target Engagement In An 18-Month Phase 2b Trial (S27.008)
- Creators
- Merit Cudkowicz - Massachusetts General HospitalVivian Drory - Tel Aviv Sourasky Medical CenterAdriano Chio - University of TurinChristian Lunetta - Istituti Clinici Scientifici MaugeriChristen Shoesmith - London Health Sciences CentreShiran ZimriNiva Russek-BlumDiana ShtosselRuben van Eijk - University Medical Center UtrechtGuy Shapira - Tel Aviv UniversityNoam Shomron - Tel Aviv UniversityFerenc TracikJeffrey Rosenfeld - Loma Linda UniversityJeremy Shefner - Barrow Neurological Institute
- Publication Details
- Neurology, Vol.104(7_Supplement_1)
- Identifiers
- 991006262236102656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
Shifting The PARADIGM: PrimeC, An Oral Candidate For Amyotrophic Lateral Sclerosis, Demonstrates Safety, Efficacy, And Target Engagement In An 18-Month Phase 2b Trial (S27.008)
Neurology, Vol.104(7_Supplement_1)
04/08/2025
Metrics
1 Record Views